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ABSTRACT: The VIPAR polymer gel dosimeter formulation was modified in an effort to elim-
inate the need for deoxygenation in the manufacturing procedure while preserving its favorable
characteristics of dose rate independence and a wide dose response range. Aiming at an adequate
dose sensitivity and the extension of dose response in the low dose region to facilitate the dose
verification of radiosurgery applications where narrow beams are employed and steep dose gra-
dients are involved, the new formulation consists of 8% N-Vinylpyrrolidone, 7.5% gelatine, 4%
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N,N′-methylenebisacrylamide, as well as of 0.0008% Copper Sulfate and 0.007% Ascorbic Acid
as oxygen scavengers. To study the dose — R2 response, dose rate dependence and “edge effect”
behaviour of the new formulation, one batch of two gel filled glass vials was prepared. Before MR
Imaging, one vial was irradiated with a brachytherapy source while the other one was irradiated
using circular CyberKnife radiation fields of 60, 10, 7.5 and 5 mm in diameter. Results of this study
suggest that the new gel dosimeter responds linearly in the dose range of about 3 to 30 Gy, whilst
the full dose response range exceeds the maximum delivered dose of 50 Gy. No dose rate depen-
dence was observed for the new gel, while Cyberknife dosimetry results in the form of stereotactic
field size and penumbra measurements suggest that the new formulation could be effective in the
dose verification of demanding radiosurgery techniques.
KEYWORDS: Dosimetry concepts and apparatus; Radiotherapy concepts; MRI (whole body, car-
diovascular, breast, others), MR-angiography (MRA)
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1 Introduction
Polymer gel dosimetry is the only inherently three-dimensional dosimetry method currently avail-
able. The dosimetric material is an aqueous solution of appropriate monomers and crosslinkers
fixed in a gelatin matrix. Hence, a water equivalent material comprises the phantom and the dosime-
ter at the same time. Radiation induced polymerization alters the spin-spin relaxation time (T2) of
the gel and, therefore, Magnetic Resonance Imaging (MRI) can be employed for dose measure-
ments with high spatial resolution.
In view of the above unique features, polymer gel — MRI dosimetry is probably the best
candidate for dose verification in demanding radiosurgery applications employing narrow beams
and steep dose gradients to deliver complex, three-dimensional (3D) dose distributions.
Among the various steps in the application of polymer gel dosimetry, manufacturing of the
dosimetric material is perhaps the most time consuming and laborious one. Normoxic formula-
tions [1] were therefore proposed to simplify gel preparation, providing at the same time speed
and increased reproducibility. In this study, a normoxic modification of the VIPAR gel formula-
tion [2] is characterized in terms of dose response, dose rate dependence and dosimetric sufficiency
in radiosurgery applications.
2 Materials and methods
2.1 Polymer gel formulation
Seeking to extend the dose response of the original VIPAR formulation in the low dose region, the
concentration of N-Vinylpyrrolidone (NVP) was doubled. Given the augmented concentration of
NVP, the concentration of gelatin had to be increased in order to ensure mechanical stiffness of the
solidified solution. Along the lines of Fong et al [1], Copper Sulfate Pentahydrate and Ascorbic
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Acid were added as oxygen scavengers [3] allowing the gel preparation procedure to be carried out
in normal atmospheric conditions.
The concentration of N,N′-methylenebisacrylamide (MBA) was maintained at its solubility
value at 21oC (4%) and, hence, the new gel formulation (hereafter to be referred to as VIP1 for sim-
plicity) was: 8% N-Vinylpyrrolidone, 7.5% gelatin, 4% N,N′-methylenebisacrylamide, 0.0008%
Copper Sulfate and 0.007% Ascorbic Acid [3].
2.2 Polymer gel preparation and irradiation
Hyperpure water was heated to 45oC and MBA was diluted under magnetic stirring. Gelatin was
subsequently added and the solution was cooled down to 30oC before the addition of NVP. The
appropriate amount of the two oxygen scavenging constituents (Copper Sulfate and Ascorbic acid)
was finally added.
Two 100 ml glass vials were used as gel containers; one cylindrical vial with a catheter fitted
through its poly-propylene cap to facilitate brachytherapy irradiation, and one long tube for Cy-
berKnife (Accuray Inc.) irradiation. The gel filled vials were tightly sealed using Parafilm, and
stored overnight in a cool, dark place to solidify before irradiation.
The brachytherapy irradiation was carried out using an 192Ir HDR remote afterloader (Nucle-
tron B.V.) programmed to deliver 15 Gy at 1 cm distance along the transversal source axis.
For the CyberKnife irradiation, 6MV X-ray radiation fields of 60, 10, 7.5 and 5 mm in di-
ameter were used to deliver 30 Gy at 15 mm depth each time, with the central beam axes being
perpendicular to the long tube axis.
2.3 MRI and data processing
Both the brachytherapy and CyberKnife irradiated vials were imaged on a Philips 1.5T scanner
using a volume selective 2 echo TSE sequence for time efficiency [4]. The main scanning parame-
ters were Turbo factor = 86, TE1 = 36 ms, TE2 = 800 ms, repetition time = 3000 ms, and acquisition
voxel = 0.5 mm3. A T2 map was calculated for each reconstructed slice using a mono-exponential
fitting routine of echo time versus signal intensity on a pixel-by-pixels basis. A 3D T2 matrix was
then constructed by the acquired T2 maps and converted to a 3D R2 (= 1/T2) relaxation rate matrix.
MATLAB custom made routines were employed for matching the measured 3D R2 distribu-
tions with the corresponding delivered dose distributions. To calculate the brachytherapy source
center and orientation during the irradiation the routine exploits the symmetry of the dose distri-
bution, or equivalently the R2 distribution symmetry. For the CyberKnife irradiations, the central
beam axis and the depth of maximum dose were calculated for each irradiation field by taking ad-
vantage of the circular symmetry in each plane perpendicular to the central beam axis of each field.
3 Results and discussion
Figure 1 presents the dose response curves for the new gel formulation obtained from the brachyther-
apy and CyberKnife irradiations. Corresponding HDR brachytherapy data for the original VIPAR
formulation [5] are also presented for comparison. Both data sets for the VIP formulation present
1The acronym VIPARnd has also been used for this formulation in a previous work [3].
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Figure 1. Dose-response curves for the new gel formulation obtained from brachytherapy and CyberKnife
irradiations. Brachytherapy data using the original VIPAR formulation are from ref. [5].
similar characteristics in terms of sensitivity, linearity and dose response range, implying that
there is no intra-batch variability of the gel material. The fabrication of the VIP gel in normal
atmospheric conditions, apart from being substantially faster and convenient, it ensures that dis-
crepancies among specimens of the same batch or between different batches are less probable in
comparison to gel manufacturing under anoxic conditions.
It should be noted, moreover, that HDR brachytherapy source irradiation involves different
dose rates with changing distance from the source. The fact that the VIP gel dosimeter response is
similar in both the brachytherapy and 6MV irradiations ensures that the dose rate independence of
the VIPAR formulation [6], for the examined dose rate range, is retained in the new formulation.
A straight line was fitted in the linear part of the VIP and VIPAR dose response curves. The
corresponding slope (sensitivity) and intercept values are also presented in figure 1. The threshold
of the linear dose response range of the manufactured VIP formulation resides in relatively lower
doses compared to the original VIPAR formulation [5, 6], owing to the increased concentration of
NVP and the almost perfect “de-oxygenation” of the solution (by using oxygen scavengers). The
new formulation presents a higher sensitivity (0.090 s−1/Gy) compared to that reported [5] for the
VIPAR formulation (0.067 s−1/Gy), implying a better dose resolution. It also appears that the VIP
gel exhibits a linear dose response up to about 30 Gy, while its dynamic dose range surpasses the
50 Gy. For comparison, VIPAR is known to be able to record doses over 100 Gy while its linear
response extends up to 45 Gy [5, 6].
The results from the measurements of the CyberKnife irradiated vial are presented in figure 2.
The 3D dose distribution as recorded by the VIP dosimeter can be clearly discerned (figure 2 top)
due to the transparency of the unirradiated gel volume. The calculated T2 map on a plane perpen-
dicular to the four beam axes and at the depth of maximum dose reveals the circular symmetry of
each field (figure 2 middle), while the R2 profile measured along the longitudinal vial axis at the
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Figure 2. Photographs of the CyberKnife irradiated VIP gel (top). The T2 map on a plane perpendicular
to the four beam axes and at the depth of maximum dose (middle). The R2 profile measured along the
longitudinal vial axis at the aforementioned plane (bottom).
same plane allows the calculation of beam characterization indices (figure 2 bottom). An over-
all good agreement, within experimental uncertainties, can be observed between the maximum
R2 value for each of the four fields, as expected by the fact that an equal dose was delivered for
each field.
The field sizes, in terms of FWHM, and the penumbral regions of all four CyberKnife beams
used were calculated to examine the new formulation’s potential for accurately recording nar-
row stereotactic fields and steep dose gradients, where lateral electronic disequilibrium condi-
tions apply.
The 5, 7.5 and 10 mm field sizes (figure 2) were found equal to 5.2 mm, 7.7 mm and 9.8 mm
respectively. These results are in good agreement with the nominal values (the 60 mm field could
not be measured since only part of the field was registered in order to preclude dose interference
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among the 4 irradiated fields). The penumbral region (20%–80%) of the 5, 7.5, 10 and 60 mm Cy-
berKnife beams (figure 2) were found equal to 2.1 mm, 2.3 mm, 2.6 mm and 3.9 mm respectively.
Corresponding diode measurements used in the treatment planning system are 2.1, 2.3, 2.6 and
3.9 mm for the same four collimators.
4 Conclusions
The VIP formulation seems to retain the favourable dose response characteristics of VIPAR (wide
dose response range, dose rate independence) while being able to record lower doses with relatively
higher sensitivity and hence improved dose resolution. The useful dose range of VIP is ideally
suited for the verification of clinical, 3D conformal applications and especially radiosurgery.
The addition of oxygen scavengers appears to render the deoxygenation step obsolete in the
fabrication of this new formulation, suggesting a high inter/intra-batch reproducibility with regard
to the dosimetric characteristics. As a result, a much easier and faster production protocol was
configured that could facilitate manufacture of polymer gel dosimeters in the clinical setting.
Overall, the obtained results suggest that the characteristics of the new gel formulation, com-
bined with the inherent three-dimensional character of the polymer gel dosimetry method, could
facilitate dosimetry of radiosurgical applications, provided that it is coupled with appropriate MRI
parameters to arrive at acceptable relative uncertainties for adequate image spatial resolution, in
practicable scanning times.
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